Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
Recruiting · NCT06148298 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Central Florida
View the official record on ClinicalTrials.gov →Interventions studied
Non-Human Subject Research study.
What this trial is about
The goal of this research is to use chromatin immunoprecipitation, a method used to study protein-DNA interaction, as a tool to diagnose and prognose pancreatic ductal adenocarcinoma in human samples. This is a Non-Human Subject Research study. All participants are de-identified.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- 18 years old or older
- Pancreatic cancer patients
Exclusion criteria
- Children may not register
- Persons who are unable to consent may not register
Where it is running
1 location listed across 1 US state.
- University of Central Florida - Orlando, Florida, United States